Nextech Invest

Venture capital firm

Nextech Invest is a Zurich, Switzerland-based venture capital firm. Value Add VC tracks 5 companies Nextech Invest has invested in and 2 venture rounds it took part in (1 as lead).

Nextech Invest key facts (as of )

FactValueSource
HeadquartersZurich, SwitzerlandSEC Form ADV (IAPD), September 16, 2026
TypeVenture capital firmValue Add VC classification
Partners and teamMelissa McCracken, Ph.D. (Partner); Rocco Sgobbo (Managing Partner, COO); Thilo Schroeder, Ph.D. (Managing Partner); Kanishka Pothula (Managing Partner)nextechinvest.com, October 24, 2026
Notable investmentsORIC Pharmaceuticalsnextechinvest.com, October 24, 2026
Venture rounds tracked2 (led 1, joined 1)
2 in the last 12 months
Recent deals table on this page (each round cites its source)
Portfolio companies tracked5Portfolio list on this page

Nextech Invest overview

Nextech Invest is a Zurich-based investor in emerging biotechnology companies developing cancer medicines and precision medicine.[1] The firm says it supports portfolio companies through critical moments of scientific and clinical validation.[2] Its team includes managing partners Thilo Schroeder, Kanishka Pothula and Rocco Sgobbo, with biotech entrepreneur Alexis Borisy as chairman.[3] Portfolio companies the firm lists as exited include Mirati Therapeutics, Blueprint Medicines, Peloton Therapeutics and Vividion Therapeutics.[2]

Recent deals we track

2

Track record: led 1 and participated in 1 of 2 tracked venture rounds · 2 in the last 12 months · led 1 Series C

DateCompanyEventRoleAmountValuationInvestorsSource
Aug 13, 2026Khartis TherapeuticsSeries BParticipated$50M—
Foresite CapitalunverifiedLilly Asia VenturesunverifiedNextech InvestunverifiedForge Life Science Partners
Pulse story
Jun 30, 2026Flare TherapeuticsSeries CLed$85M—Pulse story

Is something wrong on this page?

About Nextech Invest

Its partners and team include Melissa McCracken, Ph.D. (Partner), Rocco Sgobbo (Managing Partner, COO), Thilo Schroeder, Ph.D. (Managing Partner) and Kanishka Pothula (Managing Partner).[nextechinvest.com] Its investments include ORIC Pharmaceuticals (multiple rounds).[nextechinvest.com]

Nextech Invest partners and team

4

Notable Nextech Invest investments

1

At a glance

Nextech Invest appears in 2 funding rounds tracked by ValueAddVC since 2026, leading 1. Its most recent tracked deal was Khartis Therapeutics' $50M Series B round (Aug 13, 2026).

Strategy

Geographies
Zurich, Switzerland

Recent changes

  1. Aug 13, 2026Invested in Khartis Therapeutics (Series B, $50M) Axios
  2. Jun 30, 2026Invested in Flare Therapeutics (Series C, $85M) GlobeNewswire

Portfolio

5 total

Sector / Stage Activity

By stage (tracked rounds)
Series B
1 · 50%
Series C
1 · 50%

Co-Investors

11

Similar Firms

overlapping sector, stage or region

Latest Pulse

  1. Khartis Emerges From Stealth With $95M for a Thyroid PillKhartis Therapeutics emerged from stealth with $95 million in total funding, including a new $50 million Series B, to develop an oral alternative to injectable treatments for thyroid eye disease.→
  2. Crunchbase: The Week's 10 Biggest Funding Rounds, Led by Joulent's $1.75B Energy RaiseCrunchbase News' roundup of the week's 10 biggest funding rounds (June 27-July 2) was led by Houston-based energy infrastructure provider Joulent's $1.75 billion raise from National Grid Ventures, aimed squarely at AI and compute-intensive industries' power needs. Together AI's $800M Series C and Venice AI's $65M unicorn round both placed inside the top 10, alongside biotech, legal-tech, sports and video-AI rounds spanning a genuinely broad set of categories beyond pure frontier-model AI.→
  3. Flare Therapeutics Raises $85M, Names New CEOFlare Therapeutics closed an $85 million insider-led Series C and named Anna Protopapas CEO, funding its first-in-class ARON-targeting degrader for prostate cancer toward a Phase 1A trial expected in Q3 2026.→

Nextech Invest FAQ

What stage does Nextech Invest invest at?

In the rounds Value Add VC tracks, Nextech Invest's deals were most often Series B (1) and Series C (1); it led 1 Series C.

Who are the partners at Nextech Invest?

Nextech Invest's partners and team include Melissa McCracken, Ph.D. (Partner), Rocco Sgobbo (Managing Partner, COO), Thilo Schroeder, Ph.D. (Managing Partner) and Kanishka Pothula (Managing Partner), according to nextechinvest.com.

What companies has Nextech Invest backed?

Notable Nextech Invest investments include ORIC Pharmaceuticals (multiple rounds), according to nextechinvest.com. Companies Value Add VC tracks as Nextech Invest investments include Silence Therapeutics, Khartis Therapeutics, Attovia Therapeutics, Flare Therapeutics and Parabilis Medicines.

Where is Nextech Invest based?

Nextech Invest is headquartered in Zurich, Switzerland, according to SEC Form ADV (IAPD).

Who does Nextech Invest co-invest with most?

In the rounds Value Add tracks, Nextech Invest most often invests alongside ARCH Venture Partners (1 shared deal), Casdin Capital (1 shared deal), Deep Track Capital (1 shared deal), Eli Lilly (1 shared deal), Eli Lilly and Company (1 shared deal).

References

researched 2026-10-24
  1. Nextech Invest
  2. Nextech Invest
  3. Nextech Invest
Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·